Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Return to: PBR Home | Production & Manufacturing
Today in Production & Manufacturing

Production & Manufacturing

Actavis completes acquisition of Allergan for $70.5bn Irish pharmaceutical firm Actavis has completed the acquisition of US-based Botox maker Allergan in a cash-and-stock deal valued at about $70.5bn. Production & Manufacturing > Manufacturing > News

Latest Production & Manufacturing News by Sector

Select a sector from the list or browse by sector below:

Fine & Speciality Chemicals

Bayer plans to focus entirely on Life Science businesses
Bayer intends in the future to focus entirely on the Life Science businesses – HealthCare and CropScience – and float MaterialScience on the stock market as a separate company. In this way Bayer is positioning itself as a world-leading company in the field of human, animal and plant health.
News
CordenPharma agrees to purchase Peptisyntha from Solvay
By PBR Staff Writer
International Chemical Investors Group (ICIG) and the Solvay Group have embarked on an agreement, whereby ICIG will purchase Belgium-based Peptisyntha SA, a custom manufacturer of peptides for pharmaceutical use.
News

Process & Production

FDA approves Sandoz's Glatopa for multiple sclerosis treatment
By PBR Staff Writer
The US Food and Drug Administration (FDA) has granted approval for Sandoz's Glatopa, the first generic version of Teva’s Copaxone (glatiramer acetate injection) 20mg/ml one-time-daily multiple sclerosis (MS) therapy.
News
Baxter submits NDA to Japanese authorities seeking approval for BAX 855 to treat hemophilia A
By PBR Staff Writer
Baxter International has submitted a new drug application (NDA) to Japan's Ministry of Health, Labour and Welfare (MHLW) seeking approval for BAX 855, an investigational, extended half-life recombinant factor VIII (rFVIII) treatment based on ADVATE for patients over 12 years of age with hemophilia A.
News

OTC

Hi-Tech to buy Mexican OTC firm Advanced Pharmaceuticals and Nutritionals
By PBR Staff Writer
Hi-Tech Pharmaceuticals has entered into an agreement to acquire Advanced Pharmaceuticals and Nutritionals (APN), a Mexican OTC and dietary supplement company.
News
Actavis, Medicines360 launch Liletta 52mg to prevent pregnancy for up to three years
By PBR Staff Writer
Irish pharmaceutical company Actavis and Medicines360, a US-based nonprofit women's health pharmaceutical firm, have launched Liletta (levonorgestrel-releasing intrauterine system) 52mg in the US for use by women to prevent pregnancy for up to three years.
News

Manufacturing

Eisai to cut workforce by 25% in US
By PBR Staff Writer
Japanese pharmaceutical firm Eisai said it would cut about 25% jobs across various US functions as part of a realignment to create a more efficient and focused company.
News
Cipla EU agrees to acquire Brazilian drug distributor Duomed
By PBR Staff Writer
Indian drug-maker Cipla's UK subsidiary has entered into an agreement to acquire 100% stake in Duomed Produtos Farmaceuticos (Duomed), a Brazilian importer and distributor of pharma products, for BRL1.6m ($522,641).
News